Sign In
Buy PHG
$25.35
-0.0800 (-0.315%)
At Close: Jun 03, 2026
'Vast majority' of legal cases over apnea recall now settled: Philips CEO
09:00am, Monday, 29'th Apr 2024
Philips CEO Roy Jakobs comments on the company's first-quarter results and its agreement of a $1.1 billion settlement for personal injury and medical monitoring claims linked to the recall of some res
Why Is Koninklijke Philips (PHG) Stock Up 41% Today?
08:23am, Monday, 29'th Apr 2024
Koninklijke Philips (NYSE: PHG ) stock is climbing higher on Monday after the company announced a settlement connected to its recall of sleep apnea product Respironics. Koninklijke Philips has agreed
Philips soars after settling sleep apnea class action for $1.1bn
07:17am, Monday, 29'th Apr 2024
Dutch multinational Philips soared a remarkable 43% on Monday after settling a protracted class-action lawsuit in the US over allegedly faulty sleep apnea devices. Millions of the devices were recalle
AI sets Philips' stock price for next 12 months
06:05am, Monday, 29'th Apr 2024
The stock price of medical equipment maker Philips (NYSE: PHG) is experiencing bullish sentiments as the company strives to overcome regulatory concerns that have plagued it.
Philips shares soar 30% after U.S. litigation settlement far lower than feared
04:55am, Monday, 29'th Apr 2024
Shares of Royal Philips NV soared on Monday, after the Dutch health-technology group announced a much lower-than-expected U.S. settlement over its Respironics ventilators.
Philips shares rocket 33% as firm settles U.S. respiratory device case
04:07am, Monday, 29'th Apr 2024
Philips shares soared Monday after the company agreed a $1.1 billion settlement in a U.S. case linked to the recall of some of its sleep apnea devices.
Philips $1.1B Sleep Apnea Settlement Covers All US Claims, CEO Says
03:58am, Monday, 29'th Apr 2024
Philips CEO Roy Jakobs discusses the firm's €982 million ($1.1 billion) provision to help settle US claims linked to a recall of sleep apnea medical devices, much lower than analysts expected. The
Philips agrees to $1.1 billion settlement over U.S. ventilator recall
03:56am, Monday, 29'th Apr 2024
Dutch medical devices maker Philips announced on Monday that it has agreed to a $1.1 billion settlement regarding personal injury lawsuits in the United States. This agreement relates to the global re
Philips pays $1.1 bln in U.S. settlement over ventilator recall
01:25am, Monday, 29'th Apr 2024
Dutch medical devices maker Philips said on Monday it had agreed to pay $1.1 billion in a settlement of personal injury cases in the United States related to the global recall of ventilators used to t
Philips (PHG) Receives FDA Warning Letter Regarding CT Systems
02:20pm, Friday, 26'th Apr 2024
Philips (PHG) receives a warning letter from the FDA in respect of a manufacturing plant in China regarding faults in the manufacturing of CT systems.
Philips' (PHG) Zenition 30 to Boost Image-Guided Surgeries
11:46am, Tuesday, 23'rd Apr 2024
Philips (PHG) announces the FDA clearance for its Zenition 30 mobile C-arm, which is intended to aid in image-guided procedures at a relatively affordable cost.
Philips (PHG) Agrees to a Consent Decree With DOJ and FDA
10:40am, Tuesday, 16'th Apr 2024
Philips (PHG) announces a consent decree with the U.S. government and FDA over Respironics' business recalls.
Philips climbs as US deal on sleep apnea machines revealed
07:12am, Wednesday, 10'th Apr 2024
Philips climbed on Wednesday morning after details of an agreement with the US over its sale of potentially dangerous breathing devices in 2021 were revealed. Millions of the devices have already been
Philips announces terms of US government deal on sleep apnea machines
04:31am, Wednesday, 10'th Apr 2024
Philips announced the main terms of an agreement it reached in January with the U.S. government on its new sleep apnea machines, sending shares in the Dutch health technology firm up almost 3% on Wedn
Philips shares climb after finalizing pact with U.S. over device sales
03:30am, Wednesday, 10'th Apr 2024
Philips reiterated its financial outlook on Wednesday after finalizing a consent degree with the U.S. Department of Justice and Food and Drug Administration that will prevent it from selling new respi
